Comparing PENG block and intra-articular injection for pain relief after hip surgery
Pericapsular Nerve Group (PENG) Block Versus Intra-articular Injection for Hip Arthroscopy: A Randomized Trial
This study is testing whether a nerve block or an injection can help people having hip surgery feel less pain and recover better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Bezmialem Vakif University Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT04698746 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of the pericapsular nerve group (PENG) block compared to intra-articular local anesthetic injection for managing acute postoperative pain in patients undergoing hip arthroscopy. The study aims to determine which method provides better pain control, thereby facilitating rehabilitation and reducing reliance on opioids. Eligible participants include those scheduled for elective hip arthroscopy who meet specific health criteria. The trial will assess pain outcomes and recovery metrics following the two different pain management techniques.
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for elective hip arthroscopy with an ASA physical status of I to III and a BMI between 20 and 35 kg/m2.
Not a fit: Patients with chronic pain conditions requiring opioid intake, significant comorbidities, or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing hip arthroscopy, reducing opioid use and enhancing recovery.
How similar studies have performed: Previous studies have shown positive outcomes with regional anesthesia techniques for postoperative pain management, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * American Association of Anesthesiologists (ASA) physical status I - III * BMI 20 to 35 kg / m2 * Patients scheduled for elective hip arthroscopy * Able to provide informed consent. Exclusion Criteria: * Patients who refuse to participate in the study, * Coagulopathy, * Sepsis, * Hepatic or renal insufficiency, * Pregnancy * Allergy to local anesthetic drugs, * Chronic pain condition requiring opioid intake at home, * BMI above 40. * History of psychiatric diseases needing treatment. * Failure of nerve block * Substance abuse history * Hip revision surgery * Underlying neurologic disorder affecting pain perception. * Angina, heart attack, heart failure * Kidney or hepatic insufficiency * Stroke * Gastrintestinal bleeding history
Where this trial is running
Istanbul
- Bezmialem Vakıf University — Istanbul, Turkey (Recruiting)
Study contacts
- Principal investigator: Yeşiltaş — Bezmialem Vakif University
- Study coordinator: Serdar Yeşiltaş, Asist Prof.
- Email: syesiltas@bezmialem.edu.tr
- Phone: 05423632630
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.